Groundbreaking Alzheimer’s Treatment Shows Promise in Early Trials
Several groundbreaking treatments for Alzheimer’s disease have shown promise in recent clinical trials, signaling potential advancements in managing this challenging condition. One novel approach involves the use of cyclic peptides to halt the progression of Alzheimer’s at its early stages by targeting toxic soluble amyloid beta oligomers. This treatment was effective in pre-symptomatic transgenic mice,
Read More